Company Executives

$BBIO Management Team

Dr. Neil Kumar

Chief Executive Officer

Director

Age 46

Compensation $15.58M USD

Sex Male

Dr. Charles Homcy

Lead Director

Chairman of Pharmaceuticals

Age 76

Compensation $1.118M USD

Sex Male

Dr. Thomas Trimarchi

President

Chief Financial Officer

Age 40

Compensation $6.502M USD

Sex Male

Name / Title	Age	Compensation	Sex
Dr. Neil Kumar Chief Executive Officer Director	46	$15.58M USD	Male
Dr. Charles Homcy Lead Director Chairman of Pharmaceuticals	76	$1.118M USD	Male
Dr. Thomas Trimarchi President Chief Financial Officer	40	$6.502M USD	Male

Board of Directors

From the proxy statement filed Apr 24, 2026

Directors

serving now

Independent

11 of 14

stated in the proxy

Average tenure

6.7 years

from year joined

CEO also chairs the board

Not stated

no chair stated

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Neil Kumar CEO	47	2015 11 years	Not independent	None stated	Maze Therapeutics, Inc.	Paid as CEO
Eric Aguiar	64	2019 7 years	Independent	Audit Committee	Biomea Fusion, Inc.	$599,947
Jennifer E. Cook	60	2019 7 years	Independent	Compensation Committee	Denali Therapeutics, Inc.	$599,947
Douglas A. Dachille	61	2021 5 years	Independent	Audit Committee	Equitable Holdings, Inc.	$599,947
Ronald J. Daniels	66	2020 6 years	Independent	Compensation Committee	None stated	$599,947
Andrea J. Ellis	40	2021 5 years	Independent	None stated	None stated	$599,947
Fred Hassan Lead independent director	80	2021 5 years	Independent	None stated	EyePoint Pharmaceuticals, Inc.	$599,947
Charles Homcy	77	2018 8 years	Not independent	None stated	Maze Therapeutics, Inc.	$1,124,114
Andrew W. Lo	65	2020 6 years	Independent	Nominating and Corporate Governance Committee	G-CAR, n-Lorem, Vesalius Therapeutics, Uncommon Cures	Not stated
Frank P. McCormick	75	2023 3 years	Not independent	None stated	BridgeBio Oncology Therapeutics, Inc.	Not stated
James C. Momtazee	54	2016 10 years	Independent	None stated	Roivant Sciences, Inc.	$599,947
Ali J. Satvat	48	2016 10 years	Independent	None stated	Coherus Oncology, Inc.	$599,947
Randal W. Scott Leaving at the meeting	68	2020 6 years	Independent	Audit Committee	Talis Biomedical Corporation	Not stated
Hannah A. Valantine	74	2021 5 years	Independent	Nominating and Corporate Governance Committee	Pacific Biosciences of California, Inc.	$599,947

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 24, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments

Company Executives

$BBIO Management Team

Dr. Neil Kumar

Dr. Charles Homcy

Dr. Thomas Trimarchi

Board of Directors

Related-party transactions

No related-party transactions disclosed